Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Novartis trial marks ResearchKit first in MS

ElevateMS study will allow participants to contribute from smartphones

- PMLiVE

Stada’s €4.1bn takeover goes through

German pharma company finally comes under new ownership

- PMLiVE

Samsung deal with Takeda looks beyond biosimilars

The duo plan to develop “multiple novel biologic therapies”

- PMLiVE

BenevolentAI expands its reach opening an office in New York

The company hires Keith Hall and Daniel Neil to head up the new office

Leading Edge bolsters its delivery team

The Lucid Group company hires Francesca Worthington and Lucy Coles

- PMLiVE

Things get competitive at Lucid’s sports day!

While some look back on their school sports days with blissful memories of relay races and tug of war, others are haunted by images of overly competitive parents and injuries...

Lucid Group Communications Limited

How to choose your digital channels

Like any other areas of marketing, pharma digital communication is subject to fashion. A new technology arrives, people naturally get excited. Meanwhile, established communication technologies receive less focus (even if...

Anthill Agency

- PMLiVE

Internships: Growing the pool of recruitable talent, or cheap labour?

Porterhouse Medical discusses the pros and cons of running internship programmes.

Porterhouse Medical Group

National Institute for Health and Care Excellence NICE logo

NICE set to reject Pfizer’s leukaemia drug Besponsa

Firm plans to appeal the final appraisal determination on its orphan drug

- PMLiVE

FDA clears Pfizer’s leukaemia drug Besponsa

The breakthrough treatment is the first CD22-targeted ADC to be approved in the US

- PMLiVE

emotive appoints head of talent

Adela Zafar moves from NAVBLUE to take up the newly-created role

- PMLiVE

Lynparza approval sets up tighter bout with PARP rivals

US regulator gives AZ the go-ahead for a new maintenance indication and formulation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links